Sign In
Buy RCEL
$4.16
-0.0300 (-0.716%)
At Close: Jun 03, 2026
Bragar Eagel & Squire, P.C. Encourages Agilon, Soleno, Avita, and Coty Investors to Contact the Firm Regarding Ongoing Investigations
04:51pm, Wednesday, 03'rd Dec 2025
NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel and Squire, P. C. , a nationally recognized shareholder rights law firm, is investigating potential claims against Agilon Health, Inc. (NYSE: A
AVITA Medical to Present at the Piper Sandler 37ᵗʰ Annual Healthcare Conference
04:15pm, Monday, 24'th Nov 2025
VALENCIA, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions, today announced th
The futures are trading higher after NVIDIA Inc. (NASDAQ: NVDA) blew out its fiscal third-quarter results and offered strong forward guidance, though perhaps not as robust as Wall Street had hoped.
Avita Medical Inc. (NASDAQ:RCEL) Given Average Rating of “Reduce” by Brokerages
03:32am, Monday, 17'th Nov 2025
Shares of Avita Medical Inc. (NASDAQ: RCEL - Get Free Report) have been given an average recommendation of "Reduce" by the six ratings firms that are currently covering the firm, Marketbeat.com report
AVITA Medical, Inc. (RCEL) Discusses Advanced Wound Care Solutions and Data-Driven Approaches in Clinical Healing Transcript
08:51pm, Wednesday, 12'th Nov 2025
AVITA Medical, Inc. ( RCEL ) Discusses Advanced Wound Care Solutions and Data-Driven Approaches in Clinical Healing November 12, 2025 5:00 PM EST Company Participants Ben Atkins - Vice President of In
AVITA Medical, Inc. (RCEL) Q3 2025 Earnings Call Transcript
08:06pm, Thursday, 06'th Nov 2025
AVITA Medical, Inc. ( RCEL ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Ben Atkins - Vice President of Investor Relations & Corporate Communications Cary Vance - Independe
VALENCIA, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (“AVITA Medical,” or the “Company”), a leading therapeutic acute wound care company, today anno
New Strong Sell Stocks for Oct. 31st
05:36am, Friday, 31'st Oct 2025
FLWS, BLIN and RCEL have been added to the Zacks Rank #5 (Strong Sell) List on October 31, 2025.
AVITA Medical to Announce Third Quarter 2025 Financial Results
04:15pm, Wednesday, 29'th Oct 2025
VALENCIA, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (“AVITA Medical,” or the “Company”), a leading therapeutic acute wound care company delivering
Rosen Law Firm Encourages AVITA Medical, Inc. Investors to Inquire About Securities Class Action Investigation – RCEL
07:45pm, Tuesday, 28'th Oct 2025
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of AVITA Medical, Inc. (NASDAQ: R
AVITA Medical Welcomes Support for RECELL® in Burns in Australia
04:30pm, Tuesday, 28'th Oct 2025
Australia's Medical Services Advisory Committee (MSAC) recognizes RECELL® as safe and effective, with benefits in healing, donor site sparing, and reduced hospital stays VALENCIA, Calif., Oct. 28, 20
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical, Inc. - RCEL
02:15pm, Thursday, 23'rd Oct 2025
NEW YORK , Oct. 23, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of AVITA Medical, Inc. ("Avita" or the "Company") (NASDAQ: RCEL). Such investors are advised to c
Avita Medical Inc. (NASDAQ:RCEL) Given Average Rating of “Hold” by Brokerages
01:56am, Thursday, 23'rd Oct 2025
Shares of Avita Medical Inc. (NASDAQ: RCEL - Get Free Report) have received a consensus rating of "Hold" from the six ratings firms that are covering the company, Marketbeat reports. Two research anal
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical, Inc. - RCEL
10:00am, Saturday, 18'th Oct 2025
NEW YORK , Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of AVITA Medical, Inc. ("Avita" or the "Company") (NASDAQ: RCEL). Such investors are advised to c
AVITA Medical Announces CEO Transition
06:15pm, Thursday, 16'th Oct 2025
VALENCIA, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (“AVITA Medical”, or the “Company”), a leading therapeutic acute wound care company, today anno
